Log in to your Inderes Free account to see all free content on this page.
CellaVision
211.5
SEK
-2.76 %
CEVI
NASDAQ Stockholm
Medical Equipment & Services
Health Care
1,501 following
-2.76%
-2.76%
-3.2%
-26.69%
-15.06%
-0.24%
-34.96%
-33.8%
+1,255.77%
CellaVision is active in medical technology. The company's operations develop and market image analysis systems for diagnosing blood and other body fluids. The products are intended to replace traditional microscope analysis. Operations are conducted on a global level, primarily in the Nordic countries, Europe and North America, where customers consist of research institutes. The head office is located in Lund.
Read moreMarket cap
5.04B SEK
Turnover
4.8M SEK
Revenue
EBIT %
P/E
Dividend yield-%
Financial calendar
6.2.
2025
Annual report '24
29.4.
2025
Interim report Q1'25
6.5.
2025
General meeting '24
ShowingAll content types
Redeye: Cellavision Q3’2024 - Underlying momentum intact
CellaVision, Audiocast with teleconference, Q3'24
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio